m.achebe
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 5 September 2025 · last posted 3d
70Posts here
1Topics
2Solutions
166Likes received
78Likes given
18Badges
103Days visited
1kPosts read
Recent activity
Full stream-
The anatomy of a question that gets answered within an hour Replied, post #125 · Start Here › How to Ask · 25 Jul 2026 · 17 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
What is genuinely unknown about long-term amylin agonism Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 14 Jul 2026 · 5 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #2 · Compounds › Oral incretins · 13 Jul 2026 · 7 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #41 · Access › Pricing · 10 Jul 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Language barriers in accessing a prescription abroad Replied, post #2 · marked as the solution · Access › International · 5 Jul 2026 · 13 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #53 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes Post #51 put the caveat in the right place and I want to underline it. Endotoxin sits at the boundary between what this community can usefully discuss and what it…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #32 · Sourcing › Independent verification · 21 Jun 2026 · 12 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #57 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 0 likes Whatever the answer on Area percent versus weight percent turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #18 · Access › Insurance & coverage · 13 Jun 2026 · 14 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Coming back to: Time to steady state after a dose increase Replied, post #71 · Pharmacology › Pharmacokinetics · 7 Jun 2026 · 18 likes Thank you for the correction. I would rather find out here than later.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #130 · Practice › Storage & stability · 7 Jun 2026 · 8 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Designing a personal experiment that could change your mind — one year on Replied, post #55 · Research Methods › N-of-1 designs · 3 Jun 2026 · 4 likes Post #53 is the version of this I will quote in future. One addition. Regression to the mean explains a great many personal experiments. People start when things are at…